Linear Health Sciences is excited to announce the official close of our $1.25 million Seed round of funding. Armed with these new resources we can aggressively move forward with revolutionizing the way patients are connected to their treatments!

Led by i2E the seed round included $515,000 invested by the i2E-managed Oklahoma Seed Capital Fund, along with $250,000 from the Oklahoma Angel Fund, a new investment vehicle created and managed by i2E. Other participants include $105,000 from the i2E-managed SeedStep Angels and other angel investment of $380,000.

“We plan to put most of this investment to work in developing manufacture grade tooling and molds for our Orchid Valve IV connection,” Dennis said. “The remaining amount of the investment will be used to finance the FDA approval process and the consultants who are assisting us.”

You can read more about this release from an article in The Oklahoman HERE.